Bacterial drug screening system and method

By setting a concentration gradient grading module and semi-open microporous unit on the microfluidic chip and the adapter device, combined with the quantitative transfer function of the adapter plate, the problem of cumbersome drug delivery and sampling operations in the prior art is solved. It realizes efficient and flexible drug combination and sampling, and improves the flexibility and repeatability of the bacterial drug screening system.

CN118956574APending Publication Date: 2024-11-15PEOPLES HOSPITAL PEKING UNIV
View PDF 0 Cites 3 Cited by

Patent Information

Application Number
CN202411031890.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-30
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

The existing drug screening system based on microfluidic chips relies on high-precision liquid manipulation equipment, and the drug delivery and sampling operations are cumbersome and have poor flexibility, which limits its wide application in ordinary microbial laboratories.

Method used

A bacterial drug screening system is designed, including a microfluidic chip and an adapter, which generates a drug concentration gradient through a concentration gradient grading module and a semi-open micropore unit, and uses an adapter plate to achieve simple and efficient drug combination and sampling operations. , improve the flexibility and repeatability of the system.

Benefits of technology

It simplifies liquid sample processing, improves the flexibility and repeatability of the drug screening system, reduces the difficulty of sampling, and expands the flexibility and real-time regulatory performance of microfluidic technology in the generation of multiple types and multiple concentrations of drugs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118956574A_ABST
    Figure CN118956574A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of biomedicine, and discloses a bacterial drug screening system and method.The bacterial drug screening system comprises a micro-fluidic chip and a switching device.The micro-fluidic chip comprises a substrate and a micro-channel structure arranged on the substrate; the micro-channel structure comprises a concentration gradient grading module, a plurality of branch channels which are connected in parallel and a plurality of groups of semi-open micropore units which are connected in parallel and are arranged in a matrix, one end, deviating from the substrate, of each group of semi-open micropore units is provided with an opening, and the switching device comprises a switching plate which is provided with a plurality of groups of switching holes which are arranged in a matrix; the transfer holes and the semi-open micropore units are arranged in a one-to-one correspondence manner, and the transfer holes are used for quantitatively transferring liquid samples in the semi-open micropore units. According to the bacterial drug screening system disclosed by the invention, drug droplets with different gradient concentrations are formed through the micro-fluidic chip, and the drug droplets are quantitatively transferred through the transfer plate, so that simple and high-flux drug combination and sampling operation is realized, and the flexibility and repeatability of the bacterial drug screening system are improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biomedical technology, and in particular to a bacterial drug screening system and method. Background Art

[0002] This section merely provides background information related to the present disclosure and is not necessarily prior art.

[0003] Drug screening refers to the screening of biologically active drugs from natural products or synthetic compounds, and is a key step in the development of new drugs. Microfluidics has unique advantages in the analysis and processing of drug screening, and its high-throughput characteristics can greatly reduce the investment in labor costs. Therefore, the cell screening system based on microfluidics is a drug screening system with great potential.

[0004] At present, when using drug screening systems based on microfluidic chip technology for drug screening, cell droplet arrays are generated through certain means, and the cell droplet arrays are manipulated and analyzed. The above operations usually rely on high-precision and matching liquid manipulation equipment. The drug administration and sampling operations are relatively cumbersome and have poor flexibility, which hinders its widespread use in ordinary microbiology laboratories. Summary of the invention

[0005] The purpose of the present invention is to at least solve the problem that the drug screening system relies on high-precision and matching liquid manipulation equipment, and the drug administration and sampling operations are relatively cumbersome and have poor flexibility. This purpose is achieved through the following technical solutions:

[0006] The first aspect of the present invention provides a bacterial drug screening system, comprising:

[0007] A microfluidic chip, comprising a substrate and a microchannel structure disposed on the substrate, wherein the microchannel structure comprises a concentration gradient grading module, a plurality of branch channels connected in parallel, and a plurality of groups of semi-open microporous units connected in parallel and arranged in a matrix, wherein a plurality of outlet ends of the concentration gradient grading module are connected and communicated with a plurality of branch channels in a one-to-one correspondence, and the outlet ends of the plurality of branch channels are connected and communicated with inlet ends of a plurality of groups of semi-open microporous units, and each group of the semi-open microporous units comprises a plurality of semi-open micropores, and each of the semi-open micropores comprises a first micropore and a second micropore, and the first micropore and the second micropore are both open at one end away from the substrate;

[0008] The transfer device comprises a transfer plate, on which a plurality of groups of transfer holes arranged in a matrix are provided, the plurality of groups of transfer holes are arranged in one-to-one correspondence with the plurality of groups of semi-open micropore units, each group of the transfer holes comprises a first transfer hole and a second transfer hole which are interconnected, the first transfer hole and the second transfer hole are used for quantitatively transferring liquid samples in the semi-open micropores.

[0009] The bacterial drug screening system of the present invention is provided with a microfluidic chip and a transfer device. The microfluidic chip can generate a drug concentration gradient simply, efficiently and continuously and adjustable by providing a concentration gradient grading module and a plurality of groups of semi-open microporous units connected in parallel and arranged in a matrix. The transfer device includes a transfer plate, on which transfer holes corresponding to the semi-open microporous units are provided. Drug droplets of different gradient concentrations formed by the microfluidic chip are transferred to the transfer plate through the transfer holes to realize simple and high-throughput drug combination and sampling operations, thereby further improving the flexibility and repeatability of the bacterial drug screening system.

[0010] In addition, the bacterial drug screening system according to the present invention may also have the following additional technical features:

[0011] In some embodiments of the present invention, the adapter plate includes a first plate body and a second plate body, the second plate body is arranged at the bottom of the first plate body, and the plurality of groups of adapter holes are all arranged through the first plate body;

[0012] The first transfer hole is connected and communicated with the second transfer hole through a first connecting channel, and a diameter of the first transfer hole is greater than a diameter of the second transfer hole.

[0013] In some embodiments of the present invention, the concentration gradient grading module includes a multi-stage microfluidic channel group, each stage of the microfluidic channel group includes a plurality of mixing channels, and along the fluid flow direction, each stage of the microfluidic channel group adds one mixing channel compared with the microfluidic channel group of the previous stage, and the multiple mixing channels of the microfluidic channel group of the last stage are respectively connected to a group of semi-open microporous units, and the number of the mixing channels of the last stage is the same as the number of the semi-open microporous units in each group to form a square semi-open microporous unit array.

[0014] In some embodiments of the present invention, the concentration gradient grading module also includes a first connecting channel, the inlet end of the first connecting channel is connected and communicated with the outlet end of the microchannel group of the previous level, and the outlet end of the first connecting channel is connected and communicated with the inlet end of the microchannel group of the next level.

[0015] In some embodiments of the present invention, each of the mixing channels has the same length and extends in a serpentine shape.

[0016] In some embodiments of the present invention, each group of the semi-open microporous units corresponds to one branch channel, the inlet end of each branch channel is connected and communicated with the outlet end of the corresponding mixing channel, each group of the semi-open microporous units includes a plurality of semi-open micropores, and the outlet end of each branch channel is connected and communicated with the inlet end of each semi-open micropore;

[0017] Each of the branch channels has the same length and is arranged parallel to each other.

[0018] In some embodiments of the present invention, the first micropore is connected and communicated with the second micropore through a second connecting channel, the diameter of the first micropore is larger than the diameter of the second micropore, the first micropore is arranged correspondingly to the first transfer hole, and the second micropore is arranged correspondingly to the second transfer hole;

[0019] The second micropore is connected to and communicates with the branch channel.

[0020] In some embodiments of the present invention, the microchannel structure also includes a second connecting flow channel, and a second connecting flow channel is arranged between each of the branch channels and each of the semi-open micropores. Along the fluid flow direction, the length of each of the second connecting flow channels on the same branch channel is increased compared with the last second connecting flow channel.

[0021] In some embodiments of the present invention, the microchannel structure also includes at least two liquid inlet channels, and the two liquid inlet channels are both arranged at one end of the multi-level microfluidic channel group away from the multiple groups of semi-open microporous units, and are connected and communicated with the first-level microfluidic channel group, and one end of the two liquid inlet channels is provided with a liquid inlet.

[0022] Another aspect of the present invention provides a bacterial drug screening method, wherein the bacterial drug screening method uses any of the bacterial drug screening systems described above for screening, and the bacterial drug screening method comprises the following steps:

[0023] After the two microfluidic chips are sterilized, ethanol is introduced into the microchannel structure for infiltration, and then bacterial culture fluid is introduced to wash away the residual ethanol in the microchannel structure;

[0024] Injecting drug solution A and bacterial culture solution into one of the microfluidic chips, and injecting drug solution B and bacterial culture solution into the other microfluidic chip, so that both microfluidic chips generate a stable concentration gradient;

[0025] Reverse connection: the adapter plate is placed face down and inverted on the upper part of one of the microfluidic chips, the first adapter hole is made to correspond to the first micropore, and the first adapter hole quantitatively transfers the liquid sample in the first micropore; Forward connection: the adapter plate is placed face up, another microfluidic chip is placed inverted on the upper part of the adapter plate, the second adapter hole is made to correspond to the first micropore, and the second adapter hole quantitatively transfers the liquid sample in the first micropore;

[0026] The bacterial sample is dripped into each of the first transfer holes, and after the liquid samples in the first transfer holes and the second transfer holes are shaken evenly, the transfer plate is placed in an incubator for culture. BRIEF DESCRIPTION OF THE DRAWINGS

[0027] Various other advantages and benefits will become apparent to those of ordinary skill in the art by reading the detailed description of the preferred embodiments below. The accompanying drawings are only for the purpose of illustrating the preferred embodiments and are not to be considered as limiting the present invention. Moreover, the same reference numerals are used throughout the accompanying drawings to represent the same components. In the accompanying drawings:

[0028] Figure 1 The schematic diagram of the structure of the adapter plate of the bacterial drug screening system according to the embodiment of the present invention is schematically shown;

[0029] Figure 2 Schematically showing a side view of an adapter plate of a bacterial drug screening system according to an embodiment of the present invention;

[0030] Figure 3 for Figure 2 AA section view in;

[0031] Figure 4 for Figure 3 The enlarged view of point B in the middle;

[0032] Figure 5 A schematic diagram of a part of the structure of a microfluidic chip of a bacterial drug screening system according to an embodiment of the present invention is schematically shown;

[0033] Figure 6 A schematic diagram of a part of the structure of a microfluidic chip of a bacterial drug screening system according to an embodiment of the present invention is schematically shown;

[0034] Figure 7 for Figure 6 Enlarged view of point C in the middle;

[0035] Figure 8 The flowchart of the bacterial drug screening method according to the embodiment of the present invention is schematically shown;

[0036] Fig. 9The schematic diagram schematically shows the operation of the reverse connection step of the bacterial drug screening method according to an embodiment of the present invention;

[0037] Fig.10 The schematic diagram schematically shows the operation of the forward steps of the bacterial drug screening method according to an embodiment of the present invention.

[0038] The reference numerals are as follows:

[0039] 1. substrate; 10. first substrate; 11. second substrate; 110. through hole;

[0040] 2. adapter plate; 20. first plate body; 200. first adapter hole; 201. second adapter hole; 202. first connecting channel; 21. second plate body;

[0041] 3. Concentration gradient classification module; 30. First microchannel group; 300. First mixing channel; 31. Second microchannel group; 310. Second mixing channel; 32. Third microchannel group; 320. Third mixing channel; 33. First connecting channel;

[0042] 4. Branch channel;

[0043] 5. semi-open micropore unit; 50. semi-open micropore; 500. first micropore; 501. second micropore; 51. second connecting channel; 52. second connecting flow channel;

[0044] 6. Liquid inlet channel; 60. Liquid inlet; 61. Third connecting flow channel. DETAILED DESCRIPTION

[0045] The exemplary embodiments of the present disclosure will be described in more detail below with reference to the accompanying drawings. Although the exemplary embodiments of the present disclosure are shown in the accompanying drawings, it should be understood that the present disclosure can be implemented in various forms and should not be limited by the embodiments described herein. On the contrary, these embodiments are provided in order to enable a more thorough understanding of the present disclosure and to fully convey the scope of the present disclosure to those skilled in the art.

[0046] It should be understood that the terms used herein are only for the purpose of describing specific example embodiments and are not intended to be limiting. Unless the context clearly indicates otherwise, the singular forms "one", "an" and "said" as used herein may also be meant to include plural forms. The terms "include", "comprise", "contain", and "have" are inclusive, and therefore specify the existence of stated features, steps, operations, elements and / or parts, but do not exclude the existence or addition of one or more other features, steps, operations, elements, parts, and / or combinations thereof. The method steps, processes, and operations described herein are not interpreted as necessarily requiring them to be performed in the specific order described or illustrated, unless the execution order is clearly indicated. It should also be understood that additional or alternative steps may be used.

[0047] Although the terms first, second, third, etc. can be used in the text to describe multiple elements, components, regions, layers and / or sections, these elements, components, regions, layers and / or sections should not be limited by these terms. These terms can only be used to distinguish an element, component, region, layer or section from another region, layer or section. Unless the context clearly indicates, terms such as "first", "second" and other numerical terms do not imply order or sequence when used in the text. Therefore, the first element, component, region, layer or section discussed below can be referred to as the second element, component, region, layer or section without departing from the teaching of the example embodiments.

[0048] For ease of description, spatial relative terms may be used herein to describe the relationship of one element or feature relative to another element or feature as shown in the figure, such as "inside", "outside", "inner side", "outer side", "below", "below", "above", "above", etc. Such spatial relative terms are intended to include different orientations of the device in use or operation in addition to the orientation depicted in the figure. For example, if the device in the figure is turned over, then the elements described as "below other elements or features" or "below other elements or features" will subsequently be oriented as "above other elements or features" or "above other elements or features". Therefore, the example term "below..." can include both above and below orientations.

[0049] In the related art, when using a drug screening system based on microfluidic chip technology for drug screening, a cell droplet array is generated through certain means, and the cell droplet array is manipulated and analyzed. The above operations usually rely on high-precision and matching liquid manipulation equipment. The drug administration and sampling operations are relatively cumbersome and have poor flexibility, which hinders its widespread use in ordinary microbiology laboratories.

[0050] In view of this, the present embodiment provides a bacterial drug screening system, which aims to solve the above-mentioned technical problems by setting up a microfluidic chip and a transfer device, wherein the microfluidic chip forms drug droplets of different gradient concentrations and transfers them to the transfer device through a transfer hole, so as to achieve simple and high-throughput drug combination and sampling operations, improve the flexibility and repeatability of the bacterial drug screening system, and thus solve the above-mentioned technical problems.

[0051] like Figures 1 to 7 As shown, according to an embodiment of the present invention, a bacterial drug screening system is proposed, which includes a microfluidic chip and a switching device. The microfluidic chip includes a substrate 1 and a microchannel structure arranged on the substrate 1. The microchannel structure includes a concentration gradient grading module 3, a plurality of parallel branch channels and a plurality of groups of semi-open microporous units 5 arranged in parallel in a matrix. The substrate 1 includes a first substrate 10 and a second substrate 11. The microchannel structure is opened on the first substrate 10 and has a certain depth. The second substrate 11 is arranged on the first substrate 10. A through hole 110 is opened on the second substrate 11 at a position corresponding to the semi-open microporous unit 5, which can avoid the position of the semi-open microporous unit 5, so that the end of the microporous unit away from the first substrate 10 is an open structure, and the rest of the second substrate 11 is overlapped with the first substrate 10 to form a closed structure. The multiple outlet ends of the concentration gradient grading module 3 are connected and communicated with the multiple branch channels in a one-to-one correspondence, and the outlet ends of the multiple branch channels are connected and communicated with the inlet ends of the multiple groups of semi-open microporous units 5. The above-mentioned microchannel structure is simple, efficient and continuously adjustable to generate a drug concentration gradient. Each group of semi-open microporous units 5 includes a plurality of semi-open micropores 50, and each semi-open micropore 50 includes a first micropore 500 and a second micropore 501. The first micropore 500 and the second micropore 501 have an open end away from the substrate 1, which is convenient for sampling and switching. The switching device includes a switching plate 2, and the switching plate 2 is provided with a plurality of groups of switching holes arranged in a matrix. The plurality of groups of switching holes are arranged in a one-to-one correspondence with the plurality of groups of semi-open microporous units 5. Each group of switching holes includes a first switching hole 200 and a second switching hole 201 that are connected to each other. The first switching hole 200 and the second switching hole 201 are used to quantitatively transfer the liquid sample in the semi-open micropore 50.

[0052] The bacterial drug screening system of the present invention is provided with a microfluidic chip and a transfer device. The microfluidic chip can generate a drug concentration gradient simply, efficiently and continuously by providing a concentration gradient grading module 3 and a plurality of groups of semi-open microporous units 5 connected in parallel and arranged in a matrix. The transfer device includes a transfer plate 2, on which transfer holes corresponding to the semi-open microporous units 5 are provided. Drug droplets of different gradient concentrations formed by the microfluidic chip are transferred to the transfer plate 2 through the transfer holes to realize simple and high-throughput drug combination and sampling operations, thereby further improving the flexibility and repeatability of the bacterial drug screening system.

[0053] In some embodiments of the present invention, the adapter plate 2 includes a first plate body 20 and a second plate body 21, the second plate body 21 is arranged at the bottom of the first plate body 20, and multiple groups of adapter holes are all arranged through the first plate body 20; the first adapter hole 200 of each adapter hole is connected and communicated with the second adapter hole 201 through a first connecting channel 202, and the diameter of the first adapter hole 200 is larger than the diameter of the second adapter hole 201. Specifically, there are 25 groups of adapter holes, the matrix size is 5×5, the first adapter hole 200 and the second adapter hole 201 are both circular, wherein the diameter of the first adapter hole 200 is 3.0mm-3.4mm (for example, 3.0mm or 3.1mm or 3.2mm or 3.4mm or any value in the range of 3.0mm-3.4mm), the diameter of the second adapter hole 201 is 2.2mm-2.6mm (for example, 2.2mm or 2.3mm or 2.5mm or 2.6mm or any value in the range of 2.2mm-2.6mm), and the first adapter hole 200 and the second adapter hole 201 are connected by the first A connecting channel 202 is connected, the width of the first connecting channel 202 is 0.2mm-0.4mm (for example, 0.2mm or 0.3mm or 0.4mm or any value in the range of 0.2mm-0.4mm), the depth is 1.6mm-2.0mm (for example, 1.6mm or 1.8mm or 2.0mm or any value in the range of 1.6mm-2.0mm), and the center distance between the first adapter hole 200 and the second adapter hole 201 is 4.0mm-5.5mm (for example, 4.0mm or 4.5mm or 5.5mm or any value in the range of 4.0mm-5.5mm). By setting the adapter plate 2 matched with the semi-open micropore 50, the design of the large and small holes of the adapter plate 2 fully considers the influence of gravity factors on the droplet distribution, ensures the uniform distribution of the droplet volume after the transfer, and helps to reduce the contamination of the liquid supply end, so as to improve the performance and repeatability of the bacterial drug screening system. The adapter plate 2 has dual-mode functions of "sampling" and "cultivation", wherein the "sampling" mode is to correspond the first adapter hole 200 to the first micropore 500 of the first microfluidic core, and the first adapter hole 200 quantitatively transfers the liquid sample in the first micropore 500 to complete the sampling of the first adapter hole 200, and the second adapter hole 201 is corresponding to the first micropore 500 of the second microfluidic chip, and the second adapter hole 201 quantitatively transfers the liquid sample in the first micropore 500 to complete the sampling of the second adapter hole 201. The two samplings will not contaminate the original droplets on the microfluidic chip. The adapter plate 2 can also integrate an electrode array, which can perform electrical performance testing on the samples on the adapter plate, and further use methods such as gene testing to verify the compatibility of the adapter plate with multiple detection technologies. The "cultivation" mode is to drop the bacterial sample into each first adapter hole 200, shake the liquid samples in the first adapter hole 200 and the second adapter hole 201, and then culture them.

[0054] In this embodiment, the diameter of the first adapter hole 200 is preferably 3.0 mm, the diameter of the second adapter hole 201 is preferably 2.6 mm, the width of the first connecting channel 202 is preferably 0.2 mm, the depth is preferably 1.6 mm, and the center distance between the first adapter hole 200 and the second adapter hole 201 is preferably 4.2 mm.

[0055] In other embodiments, the matrix size of the transfer holes may also be 3×3 or 4×4 or 6×6 or 7×7 or 8×8 or 9×9 or 10×10, etc., which is not specifically limited here.

[0056] In some embodiments of the present invention, the concentration gradient grading module 3 includes a multi-stage microfluidic channel group, each stage of the microfluidic channel group includes a plurality of mixing channels, and along the fluid flow direction, each stage of the microfluidic channel group adds a mixing channel compared with the previous stage of the microfluidic channel group. The multiple mixing channels of the microfluidic channel group of the last stage are respectively connected to a group of semi-open microporous units 5, and the number of mixing channels of the last stage is the same as the number of each group of semi-open microporous units 5 to form a square semi-open microporous unit array. In this embodiment, the concentration gradient classification module 3 includes three microchannel groups, namely, the first microchannel group 30, the second microchannel group 31 and the third microchannel group 32 connected in sequence, the first microchannel group 30 includes three first mixing channels 300 in parallel, the three first mixing channels 300 have the same length and extend in a serpentine shape, the second microchannel group 31 includes four second mixing channels 310 in parallel, the four second mixing channels 310 have the same length and extend in a serpentine shape, the third microchannel group 32 includes five third mixing channels 320 in parallel, the five third mixing channels 320 have the same length and extend in a serpentine shape. The number of semi-open microporous units 5 is five groups, and the five groups of semi-open microporous units 5 correspond one to one to the five third mixing channels 320. The depth of the above-mentioned first mixing channel 300, second mixing channel 310 and third mixing channel 320 is 0.2mm-0.4mm (for example, 0.2mm or 0.3mm or 0.4mm or any value in the range of 0.2mm-0.4mm), and the width is 0.4mm-0.8mm (for example, 0.4mm or 0.5mm or 0.6mm or 0.8mm or any value in the range of 0.4mm-0.8mm).

[0057] In other embodiments, the size of the semi-open microporous unit array may also be 3×3 or 4×4 or 6×6 or 7×7 or 8×8 or 9×9 or 10×10, etc., which is not specifically limited here.

[0058] In some embodiments of the present invention, the concentration gradient grading module 3 also includes a first connecting channel 33, the inlet end of the first connecting channel 33 is connected and communicated with the outlet end of the upper microchannel group, and the outlet end of the first connecting channel 33 is connected and communicated with the inlet end of the next microchannel group. Specifically, the three first mixing channels 300 are arranged at intervals along the length direction of the first connecting channel 33, and are connected and communicated with the first connecting channel 33, the four second mixing channels 310 are arranged at intervals along the length direction of the first connecting channel 33, and are connected and communicated with the first connecting channel 33, the five third mixing channels 320 are arranged at intervals along the length direction of the first connecting channel 33, and are connected and communicated with the first connecting channel 33, and the first connecting channels 33 between each level of microchannel groups are arranged in parallel with each other. The first connecting channel 33 has a depth of 0.2mm-0.4mm (for example, 0.2mm or 0.3mm or 0.4mm or any value in the range of 0.2mm-0.4mm) and a width of 0.4mm-0.8mm (for example, 0.4mm or 0.5mm or 0.6mm or 0.8mm or any value in the range of 0.4mm-0.8mm).

[0059] In other embodiments, the concentration gradient classification module 3 can also be configured to include two-stage microfluidic channel groups, four-stage microfluidic channel groups, or five-stage microfluidic channel groups according to actual experimental requirements, and the number of mixing channels included in each microfluidic channel group can also be increased or decreased.

[0060] In other embodiments, the first mixing channel 300 , the second mixing channel 310 , and the third mixing channel 320 may also be configured as U-shaped, bow-shaped, or spiral channels.

[0061] In some embodiments of the present invention, each group of semi-open microporous units 5 corresponds to a branch channel 4, the inlet end of each branch channel 4 is connected and communicated with the outlet end of the corresponding mixing channel, and the outlet end of each branch channel 4 is connected and communicated with the inlet end of each semi-open micropore 50; the length of each branch channel 4 is the same and arranged in parallel with each other. In this embodiment, the number of branch channels 4 is five, and the five branch channels 4 are connected and communicated with the five third mixing channels 320 in a one-to-one correspondence. The five branch channels 4 are arranged in parallel with each other and have the same length. The width of each branch channel 4 is 0.2mm-0.4mm (for example, 0.2mm or 0.3mm or 0.4mm or any value in the range of 0.2mm-0.4mm), and the length is 42mm. The number of semi-open microporous units 5 is five groups, and five groups of semi-open microporous units 5 are connected and communicated with the five branch channels 4 in a one-to-one correspondence. Each group of semi-open microporous units 5 includes five semi-open micropores 50, and the five semi-open micropores 50 are arranged at intervals along the length direction of the branch channel 4.

[0062] In some embodiments of the present invention, the first micropore 500 is connected and communicated with the second micropore 501 through the second connecting channel 51, the diameter of the first micropore 500 is larger than the diameter of the second micropore 501, the first micropore 500 is correspondingly arranged with the first transfer hole 200, and the second micropore 501 is correspondingly arranged with the second transfer hole 201; the second micropore 501 is connected and communicated with the branch channel 4. The diameter of the first micropore 500 is 3.0 mm-3.4 mm (for example, 3.0 mm, 3.1 mm, 3.2 mm, 3.4 mm, or any value in the range of 3.0 mm-3.4 mm), the diameter of the second micropore 501 is 2.2 mm-2.6 mm (for example, 2.2 mm, 2.3 mm, 2.5 mm, 2.6 mm, or any value in the range of 2.2 mm-2.6 mm), the first micropore 500 and the second micropore 501 are connected through the second connecting channel 51, and the width of the second connecting channel 51 is 0.2 mm-0.4 mm (for example, 0.2 mm, 0.3 mm, or 0. 4mm or any value in the range of 0.2mm-0.4mm), the depth is 1.6mm-2.0mm (for example, 1.6mm or 1.8mm or 2.0mm or any value in the range of 1.6mm-2.0mm), the center distance between the first micropore 500 and the second micropore 501 is 4.0mm-5.5mm (for example, 4.0mm or 4.5mm or 5.5mm or any value in the range of 4.0mm-5.5mm), and annular protrusions (not shown in the figure) are arranged on the end faces of the open ends of the first micropore 500 and the second micropore 501 along the circumference, so as to facilitate the subsequent transfer droplet operation steps to be carried out effectively. The depth of the first micropore 500 and the second micropore 501 is 1.8mm. The high protrusion of the large droplets formed in the first micropore 500 facilitates sampling and transfer, and the small droplets formed in the second micropore 501 provide continuous liquid supply for the large droplets during the transfer process.

[0063] In this embodiment, the diameter of the first micropore 500 is preferably 3.0 mm, the diameter of the second micropore 501 is preferably 2.6 mm, the width of the second connecting channel 51 is preferably 0.2 mm, the depth is preferably 1.6 mm, and the center distance between the first micropore 500 and the second micropore 501 is preferably 4.2 mm.

[0064] In other embodiments, the number of the semi-open micropores 50 in each group of semi-open micropore units 5 may also be three, four, six, etc. In addition, the arrangement of the semi-open micropore units 5 may also be set to other forms according to actual needs.

[0065] In some embodiments of the present invention, the microchannel structure further includes a second connecting channel 52, and a second connecting channel 52 is provided between each branch channel 4 and each semi-open micropore 50. Along the flow direction of the fluid, the length of each second connecting channel 52 on the same branch channel 4 is increased compared with the last second connecting channel 52. Specifically, one end of the second connecting channel 52 is connected and communicated with the branch channel 4, and the other end of the second connecting channel 52 is connected and communicated with the second micropore 501. Except for the semi-open micropore 50 at the end of each branch channel 4, each second connecting channel 52 extends in a serpentine shape. The serpentine second connecting channel 52 can increase the flow distance of the liquid, ensuring that when the liquid flowing out of the third mixing channel 320 flows to each second micropore 501 through the branch channel 4, the distance to each second micropore 501 is the same.

[0066] In some embodiments of the present invention, the microchannel structure further includes at least two liquid inlet channels 6, both of which are arranged at one end of the multi-stage microchannel group away from the multiple groups of semi-open microporous units 5, and are connected and communicated with the first-stage microchannel group, and one end of the two liquid inlet channels 6 is provided with a liquid inlet 60. Specifically, the liquid inlet channels 6 are arranged at intervals along the length direction of the first connecting channel 33, and the liquid inlet 60 is provided at one end of the liquid inlet channel 6 away from the semi-open microporous unit 5. The microchannel structure further includes a third connecting channel 61, which is arranged between the two liquid inlet channels 6 and the first-stage microchannel group, and the inlet end of the third connecting channel 61 is connected and communicated with the outlet ends of the two liquid inlet channels 6, and the outlet end of the third connecting channel 61 is connected and communicated with the inlet ends of the three first mixing channels 300. When performing drug resistance evolution screening, both liquid inlets 60 are connected to an injection device. For example, the experimental drug solution is injected into the liquid inlet channel 6 using an injection pump or other equipment. The experimental drug solution passes through the concentration gradient grading module 3 to form five columns of concentration gradients and flows into the semi-open micropores 50 through the branch channel 4.

[0067] The bacterial drug screening method of this embodiment forms drug droplets of different gradient concentrations through a microfluidic chip, and adopts large and small droplets and forward and reverse connection modes through the adapter plate 2 to minimize the problem of uniform distribution volume during droplet separation due to droplet gravity, so as to achieve simple high-throughput drug combination and sampling operations, thereby increasing the repeatability and feasibility of high-throughput drug screening.

[0068] When the microfluidic chip of this embodiment is processed, the mold of the microfluidic chip is first processed, and a microchannel structure with various depths is pre-processed on the PMMA mold by machining and cutting polymethyl methacrylate (PMMA). After the mold processing is completed, an organic composite of polydimethylsiloxane (PDMS) and a curing agent of 10:1 is poured on the PMMA mold, so that some microstructures with lower heights are completely covered by the organic composite layer, and some microcolumn structures with higher heights may not be completely covered. Then cure in an oven at 80°C for 2h. After taking out the cured PDMS chip, two holes at the liquid inlet 60 are punched on the cured PDMS chip. Finally, take the glass (i.e., the second substrate 11 in the previous text) and cover it on the top of the cured PDMS chip (i.e., the first substrate 10 in the previous text), and modify the two with oxygen plasma for 25s, press the two together, and complete the production of a microfluidic chip for bacterial resistance evolution.

[0069] The bacterial drug screening system of this embodiment simplifies the complexity of liquid sample processing and improves throughput. The flexible adjustment of spatial sample gradients can improve the flexibility and real-time controllable performance of microfluidic technology in the generation of multiple types and multiple concentrations of drugs, significantly reduce the difficulty of sampling, and further expand the compatibility of the microfluidic platform with various detection technologies.

[0070] A second aspect of the present invention provides a bacterial drug screening method, such as Figures 8 to 10 As shown, the bacterial drug screening method utilizes the above-mentioned bacterial drug screening system for screening, and comprises the following steps:

[0071] Step 1: After the two microfluidic chips are sterilized, ethanol is introduced into the microchannel structure for infiltration treatment, and then bacterial culture solution is introduced to wash the residual ethanol in the microchannel structure. Specifically, both microfluidic chips are sterilized by high temperature and high pressure, and the injection pump is connected to the liquid inlet 60 of the microfluidic chip through the injection tube, and 75% ethanol is introduced into the microfluidic chip through the injection pump to infiltrate the chip for 5 minutes, and then bacterial LB broth culture solution is introduced for 10 minutes to wash the residual ethanol in the microfluidic chip.

[0072] Step 2: Inject drug A and bacterial culture solution into one of the microfluidic chips, and inject drug B and bacterial culture solution into the other microfluidic chip, so that both microfluidic chips generate a stable concentration gradient. Specifically, drug A and bacterial LB broth culture solution are injected into the first chip through two injection ports, and drug B and bacterial LB broth culture solution are injected into the second chip through two injection ports. The single-side injection flow rate is 1μL / min, and the total flow rate in the chip is 2μL / min. The two microfluidic chips can generate 10 concentrations and 50 hanging drops at the same time.

[0073] Step 3: Reverse connection: Place the adapter plate 2 upside down on one of the microfluidic chips, and make the first adapter hole 200 correspond to the first micropore 500. The first adapter hole 200 transfers the liquid sample in the first micropore 500 quantitatively. Forward connection: Place the adapter plate 2 upside down, and another microfluidic chip upside down on the adapter plate 2. Make the second adapter hole 201 correspond to the first micropore 500. The second adapter hole 201 transfers the liquid sample in the first micropore 500 quantitatively. Specifically, the adapter plate 2 is controlled by the three-dimensional mobile platform to perform sampling operations. The three-dimensional mobile platform can adjust the position of the adapter plate 2 in the horizontal and vertical directions, so that the adapter hole is aligned with and contacts the large droplet of the suspension culture in the first micropore 500 in the microfluidic chip, and the quantitative transfer of the liquid sample containing pathogens is completed. First, the reverse connection operation is performed, the adapter plate 2 is turned upside down on one of the microfluidic chips, and the first adapter hole 200 on the adapter plate 2 is brought into contact with the droplet in the first micropore 500 on the microfluidic chip to sample the first adapter hole 200. Then, the forward connection operation is performed, the adapter plate 2 is turned upside down, and another microfluidic chip is turned upside down on the adapter plate 2, and the second adapter hole 201 on the adapter plate 2 is brought into contact with the droplet in the first micropore 500 on the microfluidic chip to sample the second adapter hole 201. The above-mentioned sampling operation transfers droplets of different concentrations generated by two microfluidic chips through the adapter plate 2, and adjusts the different directions of the adapter plate 2 to sample the first adapter hole 200 and the second adapter hole 201 respectively. After the sampling is completed, the drugs of different concentrations or types in the first adapter hole 200 and the second adapter hole 201 are mixed on the adapter plate 2 by tilting back and forth, and finally a mixed droplet array with 25 concentration combinations is achieved.

[0074] Step 4: Add the bacterial sample to each first transfer hole 200, shake the liquid samples in the first transfer hole 200 and the second transfer hole 201, and then place the transfer plate 2 in an incubator for incubation. Specifically, after the bacteria are inoculated into the first transfer hole 200 with a micropipette, the droplets are tilted back and forth to mix the solutions in the first transfer hole 200 and the second transfer hole 201 under the action of gravity and tension, and finally the transfer plate 2 is placed in a 37°C incubator for incubation.

[0075] The above is only a preferred specific embodiment of the present invention, but the protection scope of the present invention is not limited thereto. Any changes or substitutions that can be easily thought of by a person skilled in the art within the technical scope disclosed by the present invention should be included in the protection scope of the present invention. Therefore, the protection scope of the present invention shall be subject to the protection scope of the claims.

Claims

1. A bacterial drug screening system, characterized in that: include: A microfluidic chip, comprising a substrate and a microchannel structure disposed on the substrate, wherein the microchannel structure comprises a concentration gradient grading module, a plurality of branch channels connected in parallel, and a plurality of groups of semi-open microporous units connected in parallel and arranged in a matrix, wherein a plurality of outlet ends of the concentration gradient grading module are connected and communicated with a plurality of branch channels in a one-to-one correspondence, and the outlet ends of the plurality of branch channels are connected and communicated with inlet ends of a plurality of groups of semi-open microporous units, and each group of the semi-open microporous units comprises a plurality of semi-open micropores, and each of the semi-open micropores comprises a first micropore and a second micropore, and the first micropore and the second micropore are both open at one end away from the substrate; The transfer device comprises a transfer plate, on which a plurality of groups of transfer holes arranged in a matrix are provided, the plurality of groups of transfer holes are arranged in one-to-one correspondence with the plurality of groups of semi-open micropore units, each group of the transfer holes comprises a first transfer hole and a second transfer hole which are interconnected, the first transfer hole and the second transfer hole are used for quantitatively transferring liquid samples in the semi-open micropores.

2. The bacterial drug screening system according to claim 1, characterized in that: The adapter plate includes a first plate body and a second plate body, the second plate body is arranged at the bottom of the first plate body, and the plurality of groups of adapter holes are all arranged through the first plate body; The first transfer hole is connected and communicated with the second transfer hole through a first connecting channel, and a diameter of the first transfer hole is greater than a diameter of the second transfer hole.

3. The bacterial drug screening system according to claim 1, characterized in that: The concentration gradient grading module includes a multi-stage microfluidic channel group, each stage of the microfluidic channel group includes a plurality of mixing channels, and along the fluid flow direction, each stage of the microfluidic channel group adds one mixing channel compared to the microfluidic channel group of the previous stage, and the multiple mixing channels of the microfluidic channel group of the last stage are respectively connected to a group of semi-open microporous units, and the number of the mixing channels of the last stage is the same as the number of the semi-open microporous units in each group to form a square array of semi-open microporous units.

4. The bacterial drug screening system according to claim 3, characterized in that: The concentration gradient classification module also includes a first connecting channel, the inlet end of the first connecting channel is connected and communicated with the outlet end of the microchannel group of the previous level, and the outlet end of the first connecting channel is connected and communicated with the inlet end of the microchannel group of the next level.

5. The bacterial drug screening system according to claim 3, characterized in that: Each of the mixing flow channels has the same length and extends in a serpentine shape.

6. The bacterial drug screening system according to claim 3, characterized in that: Each group of the semi-open microporous units corresponds to one branch channel, the inlet end of each branch channel is connected and communicated with the outlet end of the corresponding mixing channel, and the outlet end of each branch channel is connected and communicated with the inlet end of each semi-open microporous unit; Each of the branch channels has the same length and is arranged parallel to each other.

7. The bacterial drug screening system according to claim 1, characterized in that: The first micropore is connected and communicated with the second micropore through a second connecting channel, the diameter of the first micropore is larger than the diameter of the second micropore, the first micropore is arranged correspondingly to the first adapter hole, and the second micropore is arranged correspondingly to the second adapter hole; The second micropores are connected to and communicate with the branch channels.

8. The bacterial drug screening system according to claim 1, characterized in that: The microchannel structure also includes a second connecting flow channel, and the second connecting flow channel is arranged between each branch channel and each semi-open micropore. Along the fluid flow direction, the length of each second connecting flow channel on the same branch channel is longer than the last second connecting flow channel.

9. The bacterial drug screening system according to claim 1, characterized in that: The microchannel structure also includes at least two liquid inlet channels, which are both arranged at one end of the multi-level microfluidic channel group away from the multiple groups of semi-open microporous units, and are connected and communicated with the first-level microfluidic channel group, and one end of the two liquid inlet channels is provided with a liquid inlet.

10. A bacterial drug screening method, characterized in that: The bacterial drug screening method is performed using a bacterial drug screening system as claimed in any one of claims 1 to 9, and the bacterial drug screening method comprises the following steps: After the two microfluidic chips are sterilized, ethanol is introduced into the microchannel structure for infiltration, and then bacterial culture fluid is introduced to wash away the residual ethanol in the microchannel structure; Injecting drug solution A and bacterial culture solution into one of the microfluidic chips, and injecting drug solution B and bacterial culture solution into the other microfluidic chip, so that both microfluidic chips generate a stable concentration gradient; Reverse connection: the adapter plate is placed upside down on the upper part of one of the microfluidic chips, the first adapter hole is matched with the first micropore, and the first adapter hole quantitatively transfers the liquid sample in the first micropore; Forward connection: the adapter plate is placed upside down, another microfluidic chip is placed upside down on the adapter plate, the second adapter hole is matched with the first micropore, and the second adapter hole quantitatively transfers the liquid sample in the first micropore; The bacterial sample is dripped into each of the first transfer holes, and after the liquid samples in the first transfer holes and the second transfer holes are shaken evenly, the transfer plate is placed in an incubator for culture.

Citation Information

Cited By

  • Micro-fluidic chip, system and method for drug resistance evolution of bacteria

    CN118931691A

  • Micro-fluidic chip and anti-corrosion microorganism detection device

    CN119549212A

  • Microfluidic Chip and Anticorrosion Microorganism Detection Device

    CN119549212B